ROCHESTER, N.Y., April 3, 2020 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology, announced the successful use of Vuzix Blade® Smart Glasses for telehealth in Thailand, specifically in the care of COVID-19 patients.
Thailand-based Tely360 (tely360.com), a software integration partner of Vuzix, presented their solution to Chakri Naruebodindra Medical Institute at the Faculty of Medicine Ramathibodi Hospital, Mahidol University in Thailand. The institute has come to an agreement with Tely360 regarding the use of their Ambulance 3rd Eye module in support of efforts to care for COVID-19 patients. The institute is one of the main sites in Thailand used for the quarantine of COVID-19 patients.
Tely360's Ambulance 3rd Eye module, used with the Vuzix Blade, aids in the communication between healthcare personnel working in a negative pressure room and physicians outside the room. This system allows the physicians to see and hear what is going on with the patient in the other room in real time. As such, the physicians are able to provide appropriate and timely directions.
"Use of the Vuzix Blade not only enhances efficiency in patient care, but also mitigates risks to personnel by reducing the number of staff in close proximity to the patient," said Paul Travers, Vuzix President and Chief Executive Officer.
About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 150 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2020 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, and Tokyo, Japan. For more information, visit Vuzix website, Twitter and Facebook pages.
Forward-Looking Statements Disclaimer
Certain statements contained in this news release are "forward-looking statements" within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward looking statements contained in this release relate to the Vuzix Smart Glasses, our business relationship with Tely360 and the use of the Vuzix Blade to enhance patient care efficiency and among other things the Company's leadership in the Smart Glasses and AR display industry. They are generally identified by words such as "believes," "may," "expects," "anticipates," "should" and similar expressions. Readers should not place undue reliance on such forward-looking statements, which are based upon the Company's beliefs and assumptions as of the date of this release. The Company's actual results could differ materially due to risk factors and other items described in more detail in the "Risk Factors" section of the Company's Annual Reports and MD&A filed with the United States Securities and Exchange Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com or www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changed events or circumstances that occur after the date of this release, except as required by applicable law.
Brian Calus, Director of North American Sales, Vuzix Corporation [email protected]
Media and Investor Relations Contact
Ed McGregor, Director of Investor Relations, Vuzix Corporation [email protected] Tel: (585) 359-5985
SOURCE Vuzix Corporation